
AOD9604
CAS: 221231-10-3
AOD9604 is a research peptide in the glp-1 / weight management category. AOD9604 is a modified 16-amino acid fragment of human growth hormone spanning residues 176-191 with a tyrosine substitution. MiPeptidos offers AOD9604 in 3 sizes with 99.8% verified purity and full analytical documentation.
How AOD9604 Works
AOD9604 is a modified 16-amino acid fragment of human growth hormone spanning residues 176-191 with a tyrosine substitution. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) without affecting blood glucose levels or growth parameters. Unlike full HGH, it does not compete for the GH receptor and does not induce IGF-1 elevation or insulin resistance, specifically targeting fat metabolism pathways.
Research Applications
Pricing
| Size | Per Vial | 10-Pack |
|---|---|---|
2mg | $16.95 | $123.95 |
5mg | $31.95 | $232.95 |
10mgBest Value | $54.95 | $400.95 |
Prices shown per vial from 10-pack. Volume discounts available for 50+ vials — contact us.
HPLC Purity Analysis
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every MiPeptidos order.
Reconstitution Calculator
Inject bacteriostatic water slowly along the vial wall. Gently swirl until dissolved — never shake. Store reconstituted solution at 2-8°C and use within 30 days.
Download Product Brochure
Get our detailed AOD9604 product brochure with specifications, research applications, HPLC analysis data, and reconstitution guide. Available in English and Spanish.
Customer Reviews
Frequently Asked Questions
Specifications
Sequence
YLRIVQCRSVEGSCGF (16 amino acids; HGH residues 176-191 with Tyr at N-terminus replacing Phe)
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides

Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.

Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for its effects on glucose metabolism and body weight regulation. One of the most researched peptides in the incretin class.

Retatrutide
A triple agonist targeting GIP, GLP-1, and glucagon receptors. Investigated in preclinical and clinical research for its multi-pathway approach to metabolic regulation.

Liraglutide
A GLP-1 receptor agonist with an extended half-life due to fatty acid acylation. Extensively studied for glucose homeostasis and appetite signaling research.